CA27.29 as a tumour marker for risk evaluation and therapy monitoring in primary breast cancer patients.

B Rack; J Jückstock; Elisabeth Katharina Trapp; T Weissenbacher; M Alunni-Fabbroni; A Schramm; P Widschwendter; K Lato; T Zwingers; R Lorenz; H Tesch; A Schneeweiss; P Fasching; S Mahner; MW Beckmann; W Lichtenegger; W Janni; SUCCESS Study Group

doi:10.1007/s13277-016-5171-2

CA27.29 as a tumour marker for risk evaluation and therapy monitoring in primary breast cancer patients.

B Rack
, J Jückstock
, Elisabeth Katharina Trapp
, T Weissenbacher
, M Alunni-Fabbroni
, A Schramm
, P Widschwendter
, K Lato
, T Zwingers
, R Lorenz
, H Tesch
, A Schneeweiss
, P Fasching
, S Mahner
, MW Beckmann
, W Lichtenegger
, W Janni
, SUCCESS Study Group

Publikation: Beitrag in Fachzeitschrift › Originalarbeit

8 Quellenangaben (Web of Science)

Originalsprache	Englisch
Fachzeitschrift	Tumor Biology
DOIs	https://doi.org/10.1007/s13277-016-5171-2
Publikationsstatus	Veröffentlicht - 2016

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

SDG 3 – Gute Gesundheit und Wohlergehen

Wissenschaftszweige

302 Klinische Medizin

Zugriff auf Dokument

10.1007/s13277-016-5171-2

Andere Dateien und Links

Dieses zitieren

Rack, B., Jückstock, J., Trapp, E. K., Weissenbacher, T., Alunni-Fabbroni, M., Schramm, A., Widschwendter, P., Lato, K., Zwingers, T., Lorenz, R., Tesch, H., Schneeweiss, A., Fasching, P., Mahner, S., Beckmann, MW., Lichtenegger, W., Janni, W., & SUCCESS Study Group (2016). CA27.29 as a tumour marker for risk evaluation and therapy monitoring in primary breast cancer patients. Tumor Biology. https://doi.org/10.1007/s13277-016-5171-2

@article{d69e97bb1d9d4d57998aaddb5249a662,

title = "CA27.29 as a tumour marker for risk evaluation and therapy monitoring in primary breast cancer patients.",

author = "B Rack and J J{\"u}ckstock and Trapp, \{Elisabeth Katharina\} and T Weissenbacher and M Alunni-Fabbroni and A Schramm and P Widschwendter and K Lato and T Zwingers and R Lorenz and H Tesch and A Schneeweiss and P Fasching and S Mahner and MW Beckmann and W Lichtenegger and W Janni and \{SUCCESS Study Group\}",

year = "2016",

doi = "10.1007/s13277-016-5171-2",

language = "English",

journal = "Tumor Biology",

issn = "1010-4283",

publisher = "SAGE Publications Ltd",

}

Rack, B, Jückstock, J, Trapp, EK, Weissenbacher, T, Alunni-Fabbroni, M, Schramm, A, Widschwendter, P, Lato, K, Zwingers, T, Lorenz, R, Tesch, H, Schneeweiss, A, Fasching, P, Mahner, S, Beckmann, MW, Lichtenegger, W, Janni, W & SUCCESS Study Group 2016, 'CA27.29 as a tumour marker for risk evaluation and therapy monitoring in primary breast cancer patients.', Tumor Biology. https://doi.org/10.1007/s13277-016-5171-2

TY - JOUR

T1 - CA27.29 as a tumour marker for risk evaluation and therapy monitoring in primary breast cancer patients.

AU - Rack, B

AU - Jückstock, J

AU - Trapp, Elisabeth Katharina

AU - Weissenbacher, T

AU - Alunni-Fabbroni, M

AU - Schramm, A

AU - Widschwendter, P

AU - Lato, K

AU - Zwingers, T

AU - Lorenz, R

AU - Tesch, H

AU - Schneeweiss, A

AU - Fasching, P

AU - Mahner, S

AU - Beckmann, MW

AU - Lichtenegger, W

AU - Janni, W

AU - SUCCESS Study Group

PY - 2016

Y1 - 2016

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000387538700077

UR - https://pubmed.ncbi.nlm.nih.gov/27481512

U2 - 10.1007/s13277-016-5171-2

DO - 10.1007/s13277-016-5171-2

M3 - Research article

C2 - 27481512

SN - 1010-4283

JO - Tumor Biology

JF - Tumor Biology

ER -